\u00a0<\/span><\/p>\nFor the trial, which will be conducted with the University\u2019s Jennifer Miller, M.D., participants will undergo preparatory psychotherapy sessions leading to two dosing sessions, which will be followed up with multiple integration sessions with the therapists.<\/p>\n
Director of the\u00a0Behavioral Health and Technology Research Clinic\u00a0and professor in the Department of Psychology at the University of Florida, Jesse Dallery, Ph.D., said: “Establishing definitive guidelines and training for the psychotherapy portion of psychedelic therapies is essential to minimizing variability and optimizing the patient experience. I was thoroughly impressed with the rigor and scientific basis of the training provided by Fluence for our upcoming study with Tryp Therapeutics and look forward to initiating our work with patients later this year.\u201d<\/p>\n
President and CSO of Tryp, Jim Gilligan, Ph.D., added: \u201cWe continue to be amazed by the complexity of neural networks and the array of biological and behavioural factors that influence the healthy functioning of the brain and body.<\/p>\n
\u201cOur partners at the University of Florida have shown tremendous commitment to the effective administration of psychotherapy for our upcoming Phase 2a clinical trial, and Fluence continues to be an exceptional partner for the design and implementation of this important component of our therapies. The completion of this psychotherapy training marks a significant milestone for Tryp, as it remains an integral part of our novel treatment.\u201d<\/p>\n
Tryp Therapeutics, Fluence and the University of Florida have collaborated to create a comprehensive training manual for the psychotherapy portion of Tryp’s psychedelic treatment regimen that will be adapted for subsequent clinical trials in\u00a0fibromyalgia\u00a0and other chronic pain indications.<\/p>\n","protected":false},"excerpt":{"rendered":"
Tryp says the training represents a best-in-class approach for psychotherapy that will accompany the administration of psilocybin.<\/p>\n","protected":false},"author":20,"featured_media":16162,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_cbd_carousel_blocks":"[]","content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[213,215],"tags":[48,223,221,225],"yoast_head":"\n
Tryp completes psychotherapy training for University of Florida study<\/title>\n<meta name=\"description\" content=\"Tryp Therapeutics has completed psychotherapy training for its upcoming Phase 2a psilocybin clinical trial.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tryp completes psychotherapy training for University of Florida study\" \/>\n<meta property=\"og:description\" content=\"Tryp Therapeutics has completed psychotherapy training for its upcoming Phase 2a psilocybin clinical trial.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/\" \/>\n<meta property=\"og:site_name\" content=\"Psychedelic Health\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-02T08:30:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-21T14:52:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/34.142.66.208\/wp-content\/uploads\/2021\/08\/Psychotherapy-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1706\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Stephanie Price\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@https:\/\/twitter.com\/steph_jprice\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Stephanie Price\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/\",\"url\":\"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/\",\"name\":\"Tryp completes psychotherapy training for University of Florida study\",\"isPartOf\":{\"@id\":\"https:\/\/34.142.66.208\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2021\/08\/Psychotherapy-scaled.jpg\",\"datePublished\":\"2021-09-02T08:30:13+00:00\",\"dateModified\":\"2021-10-21T14:52:07+00:00\",\"author\":{\"@id\":\"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12\"},\"description\":\"Tryp Therapeutics has completed psychotherapy training for its upcoming Phase 2a psilocybin clinical trial.\",\"breadcrumb\":{\"@id\":\"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/#primaryimage\",\"url\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2021\/08\/Psychotherapy-scaled.jpg\",\"contentUrl\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2021\/08\/Psychotherapy-scaled.jpg\",\"width\":2560,\"height\":1706,\"caption\":\"Psychedelics association launches, calling for operating standards\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/34.142.66.208\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tryp completes psychotherapy training for University of Florida study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/34.142.66.208\/#website\",\"url\":\"https:\/\/34.142.66.208\/\",\"name\":\"Psychedelic Health\",\"description\":\"News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/34.142.66.208\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12\",\"name\":\"Stephanie Price\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/34.142.66.208\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg\",\"contentUrl\":\"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg\",\"caption\":\"Stephanie Price\"},\"description\":\"Stephanie is the editor of Psychedelic Health. Contact: stephanie@psych.global. Stephanie is a journalist writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, and in 2015, received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, Boulder, and a certificate from the Medical Cannabis Clinicians Society on \\\"Medical Cannabis Explained\\\".\",\"sameAs\":[\"https:\/\/psychedelichealth.co.uk\",\"https:\/\/twitter.com\/https:\/\/twitter.com\/steph_jprice\"],\"url\":\"https:\/\/psychedelichealth.co.uk\/author\/stephanieprice\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Tryp completes psychotherapy training for University of Florida study","description":"Tryp Therapeutics has completed psychotherapy training for its upcoming Phase 2a psilocybin clinical trial.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/","og_locale":"en_GB","og_type":"article","og_title":"Tryp completes psychotherapy training for University of Florida study","og_description":"Tryp Therapeutics has completed psychotherapy training for its upcoming Phase 2a psilocybin clinical trial.","og_url":"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/","og_site_name":"Psychedelic Health","article_publisher":"https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks","article_published_time":"2021-09-02T08:30:13+00:00","article_modified_time":"2021-10-21T14:52:07+00:00","og_image":[{"width":2560,"height":1706,"url":"https:\/\/34.142.66.208\/wp-content\/uploads\/2021\/08\/Psychotherapy-scaled.jpg","type":"image\/jpeg"}],"author":"Stephanie Price","twitter_card":"summary_large_image","twitter_creator":"@https:\/\/twitter.com\/steph_jprice","twitter_misc":{"Written by":"Stephanie Price","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/","url":"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/","name":"Tryp completes psychotherapy training for University of Florida study","isPartOf":{"@id":"https:\/\/34.142.66.208\/#website"},"primaryImageOfPage":{"@id":"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/#primaryimage"},"image":{"@id":"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/#primaryimage"},"thumbnailUrl":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2021\/08\/Psychotherapy-scaled.jpg","datePublished":"2021-09-02T08:30:13+00:00","dateModified":"2021-10-21T14:52:07+00:00","author":{"@id":"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12"},"description":"Tryp Therapeutics has completed psychotherapy training for its upcoming Phase 2a psilocybin clinical trial.","breadcrumb":{"@id":"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/#primaryimage","url":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2021\/08\/Psychotherapy-scaled.jpg","contentUrl":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2021\/08\/Psychotherapy-scaled.jpg","width":2560,"height":1706,"caption":"Psychedelics association launches, calling for operating standards"},{"@type":"BreadcrumbList","@id":"https:\/\/34.142.66.208\/2021\/09\/02\/tryp-completes-psychotherapy-training-for-university-of-florida-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/34.142.66.208\/"},{"@type":"ListItem","position":2,"name":"Tryp completes psychotherapy training for University of Florida study"}]},{"@type":"WebSite","@id":"https:\/\/34.142.66.208\/#website","url":"https:\/\/34.142.66.208\/","name":"Psychedelic Health","description":"News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/34.142.66.208\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/34.142.66.208\/#\/schema\/person\/188c12739a5906cf0b69fbf53f517f12","name":"Stephanie Price","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/34.142.66.208\/#\/schema\/person\/image\/","url":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg","contentUrl":"https:\/\/psychedelichealth.co.uk\/wp-content\/uploads\/2023\/05\/avatar_user_20_1684313043-96x96.jpg","caption":"Stephanie Price"},"description":"Stephanie is the editor of Psychedelic Health. Contact: stephanie@psych.global. Stephanie is a journalist writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, and in 2015, received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, Boulder, and a certificate from the Medical Cannabis Clinicians Society on \"Medical Cannabis Explained\".","sameAs":["https:\/\/psychedelichealth.co.uk","https:\/\/twitter.com\/https:\/\/twitter.com\/steph_jprice"],"url":"https:\/\/psychedelichealth.co.uk\/author\/stephanieprice\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/posts\/16161"}],"collection":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/comments?post=16161"}],"version-history":[{"count":0,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/posts\/16161\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/media\/16162"}],"wp:attachment":[{"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/media?parent=16161"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/categories?post=16161"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/psychedelichealth.co.uk\/wp-json\/wp\/v2\/tags?post=16161"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}